Epic Bio to Present Preclinical Data at 28th International Annual Congress of the World Muscle Society
September 28, 2023 09:00 ET
|
Epic Bio
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today...
Dyadic and bYoRNA Announce a Collaboration Targeting the Production of Abundant, Low-Cost mRNA From C1-Cells
September 26, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla. and PARIS, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI) and bYoRNA SAS ("bYoRNA") today announced that they entered into a development and...
Epic Bio to Present at Upcoming BMO Biopharma Spotlight Series Event
September 19, 2023 09:00 ET
|
Epic Bio
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today...
Epic Bio Reports Discovery of Exceptionally Durable Gene Activators and Creation of Machine Learning Algorithm to Design New Activators
September 14, 2023 12:00 ET
|
Epic Bio
- Vast high-throughput screening study used to train unique machine learning algorithm to design synthetic activators - - Rational engineering produced activators that induce the most...
Caribou Biosciences to Participate in Upcoming Investor Conferences
August 29, 2023 16:00 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the company’s...
Asia Pacific Emerges as Global Gene Editing Market Hotspot with High Growth Projections to 2028
August 28, 2023 05:13 ET
|
Research and Markets
Dublin, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Gene Editing Market by Product & Service (Reagents, Consumables, Systems, Software), Technology (CRISPR, TALEN, ZFN, Antisense), Application...
Global CRISPR Research Report 2023: The Future of Revolutionary Gene Editing Technology - Changing the Landscape of Healthcare and Biotechnology
August 03, 2023 05:13 ET
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Global CRISPR Market by Product (Enzymes, Kits, Libraries), Services (gRNA Design, Cell Line Engineering, Screening), Application (Drug Discovery &...
CRISPR Market is Expected to Reach $7.1 Billion | MarketsandMarkets.
July 28, 2023 11:00 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, July 28, 2023 (GLOBE NEWSWIRE) -- In the near future, the CRISPR industry is poised for transformative breakthroughs that will revolutionize medicine, agriculture, and biotechnology. With...
$2.34Bn Growth for Mice Model Market Size to Hit 5.4% CAGR with CRISPR Segment Driving Growth During 2022-2028
July 25, 2023 09:19 ET
|
The Insight Partners
Pune, India, July 25, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Mice Model Market Size Report and Forecast to 2028 - COVID-19 Impact and Global...
France Gene Editing Technology Business and Investment Opportunities 2023: A $532.2 Million Market by 2027
June 28, 2023 04:08 ET
|
Research and Markets
Dublin, June 28, 2023 (GLOBE NEWSWIRE) -- The "France Gene Editing Technology Databook 2023" has been added to ResearchAndMarkets.com's offering.France's gene editing technology market is forecast...